Toward New Models for Innovative Governance of Biomedicine and Health Technologies

Oecd

No 11, OECD Science, Technology and Industry Policy Papers from OECD Publishing

Abstract: This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development and approval of new medical products and thereby to improve the understanding of the risk/benefit balance. It also identifies some of the main challenges for policy makers, regulators and other communities involved in the translation of biomedical innovation and health technologies from the laboratory bench to point of care.

Date: 2013-12-05
New Economics Papers: this item is included in nep-hea
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/5k3v0hljnnlr-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:stiaac:11-en

Access Statistics for this paper

More papers in OECD Science, Technology and Industry Policy Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().